Yahoo · Nov 6, 2026
Here's Why You Should Retain MMSI Stock in Your Portfolio for Now
Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key challenges.
NASDAQ · MMSI
Healthcare · Medical - Instruments & Supplies
$84.41
Down-$1.52 (-1.77%)
Updated Nov 20, 2026, 2:01 AM
SID Score
3.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MMSI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
MMSI closed at $84.41 after 21 trading sessions, down 10.14% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $85.18 | $86.915 | $84.06 | $84.41 | 579.43K |
| Nov 18, 2026 | $84.36 | $86.37 | $83.89 | $85.93 | 493.82K |
| Nov 17, 2026 | $85.69 | $86.31 | $84.145 | $84.49 | 630.48K |
| Nov 16, 2026 | $86.90 | $87.565 | $85.89 | $86.35 | 525.39K |
| Nov 13, 2026 | $86.95 | $87.365 | $85.97 | $86.63 | 421.76K |
| Nov 12, 2026 | $88.28 | $89.53 | $85.57 | $86.69 | 540.03K |
| Nov 11, 2026 | $87.67 | $88.38 | $86.3555 | $88.07 | 441.98K |
| Nov 10, 2026 | $87.97 | $89.01 | $87.21 | $87.81 | 480.46K |
| Nov 9, 2026 | $88.00 | $89.30 | $87.44 | $88.42 | 507.1K |
| Nov 6, 2026 | $88.33 | $88.96 | $87.045 | $87.23 | 354.02K |
| Nov 5, 2026 | $91.18 | $92.92 | $88.795 | $89.62 | 940.19K |
| Nov 4, 2026 | $87.03 | $91.40 | $85.71 | $90.63 | 1.39M |
| Nov 3, 2026 | $84.04 | $85.055 | $83.56 | $84.16 | 851.04K |
| Nov 2, 2026 | $86.26 | $86.34 | $83.72 | $84.31 | 1.2M |
| Oct 30, 2026 | $91.00 | $92.445 | $84.00 | $86.24 | 1.8M |
| Oct 29, 2026 | $93.09 | $93.78 | $91.30 | $93.39 | 979.23K |
| Oct 28, 2026 | $92.71 | $94.12 | $92.0103 | $92.21 | 543.39K |
| Oct 27, 2026 | $94.20 | $94.45 | $93.12 | $93.53 | 731.98K |
| Oct 26, 2026 | $93.42 | $94.85 | $93.30 | $94.20 | 1M |
| Oct 23, 2026 | $93.57 | $93.87 | $92.77 | $93.30 | 750.56K |
| Oct 22, 2026 | $91.40 | $94.16 | $89.1286 | $93.94 | 655.04K |
The latest Smart Investors Daily articles mentioning MMSI.
Company
Market Activity
Research & News
MMSI research
Company profile and research snapshot.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 12, 2026 | Freedom Capital Markets | Hold | — |
| Oct 30, 2026 | Needham | Buy | — |
| Oct 30, 2026 | BTIG | Buy | — |
| Oct 30, 2026 | JP Morgan | Overweight | — |
| Oct 30, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 6, 2026
Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key challenges.
Yahoo · Nov 5, 2026
HSIC vs. MMSI: Which Stock Is the Better Value Option?
Yahoo · Nov 5, 2026
The 6-month target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectivelyThe real-world patency results observed in the WRAP Global Registry are higher than the patency results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial, validating the already favorable performance of the device SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NA
Yahoo · Nov 4, 2026
COR's Q4 earnings and revenues beat estimates as specialty drug demand fuels growth and margins expand. The company raises its fiscal 2027 outlook.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MMSI.